For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Bekijk de site in het Nederlands

The only curative treatment option for many patients that suffer from a liver disorder remains whole liver transplantation. This is an invasive procedure, which is accompanied by increased morbidity and mortality. In search of alternative treatment options, several research groups have performed animal studies investigating liver-directed cell and gene therapy for the treatment of acture liver failure, chronic liver disease and inherited metabolic liver disorders. A problem is translating results of animal studies to a treatment for patients with liver disease is the difference in liver physiology between humans and rodents. Ebtisam El Filali has set out to develop a mouse with a ‘humanized liver’, which would serve as an excellent in vivo model for studies on liver-directed cell and gene therapy.

Event details of Mice with humanized liver endothelium
Date 24 September 2014
Time 12:00 -13:00
Location Agnietenkapel

E. El Filali, Mice with Humanized Liver Endothelium.

Supervisor

Prof. R.P.J. Oude Elferink

Co-supervisor

Dr J.E. Seppen

Agnietenkapel

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.